Delivery Order SPE2DB22D2009-SPE2DB25FM1CH
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 40 mg capsules (100-count) valued at $2,057.66. The contract, which closed on August 28, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be fulfilled from the contractor's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,089.66 to AmerisourceBergen Drug Corp for Lisdexamfetamine 40 mg capsules (100-count units). The contract is classified as a firm fixed-price delivery order with an ultimate completion date of August 18, 2025. This award was made through open competition with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Lisdexamfetamine 70 mg capsules (100 count) valued at $1,426.80. The contract is a firm fixed-price delivery order with a completion date of August 8, 2025, and carries no set-aside designation, indicating it was awarded through open competition. This order will be fulfilled at the vendor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,883.72 for Lisdexamfetamine 30 mg capsules (100-count units) on July 30, 2025, with an ultimate completion date of July 31, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded delivery order under the company's broader pharmaceutical supply arrangements with DLA. The product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a $1,706.90 firm fixed price delivery order to AmerisourceBergen Drug Corp for Lisdexamfetamine 10 mg capsules (100 count) on August 1, 2025, with an ultimate completion date of August 4, 2025. This non-set-aside contract was performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's broader pharmaceutical supply relationship with the DLA. This award is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 50 mg capsules (100 count) with a ceiling value of $6,451.66. The contract was awarded on August 20, 2025, with an ultimate completion date of August 21, 2025, under a firm fixed-price delivery order arrangement. No set-aside designation was utilized in this competitive procurement. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 50 mg capsules (100-count) with a ceiling value of $1,426.80. This contract, awarded on August 15, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 18, 2025, and was competitively awarded without set-aside designation. The pharmaceutical product will be delivered from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,198.41 for Lisdexamfetamine 40 mg capsules (100 count) on July 28, 2025, with completion expected by July 29, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply agreement. The pharmaceutical product will be delivered to the company's distribution facility in Conshohocken,...
- The Defense Logistics Agency awarded a $9,594.39 delivery order to AmerisourceBergen Drug Corp for Lisdexamfetamine 40 mg capsules (100-count units) on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,977.61 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 30 mg capsules (100 count) on August 22, 2025, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price delivery order was issued under a child contract arrangement with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB25FM1CHDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 60 mg capsules (100-count units) under a firm fixed price contract valued at $3,094.80, with an ultimate completion date of August 26, 2025. This non-set-aside competitive award was issued on August 25, 2025, with performance to occur at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's ongoing pharmaceutical supply relationship with the federal government, leveraging the company's established infrastructure as a major healthcare solutions provider and critical vendor for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The IDC serves as a comprehensive contracting mechanism enabling AmerisourceBergen to supply a broad portfolio of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and vaccines. As a prime contractor under this significant federal vehicle, AmerisourceBergen demonstrates substantial capability to meet the Defense Logistics Agency's medical procurement requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 8/25/25 |